Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Androgen Independent Prostate Cancer

PSA Drop Seen with New Prostate Cancer Drug

Half of a group of men with castration-resistant prostate cancer (CRPC) had biochemical responses to treatment with an investigational androgen receptor modulator, data from a preliminary clinical study showed.

During 12 weeks of treatment with galeterone, prostate-specific antigen (PSA) declined by at least 30% in 24 of 49 patients, 11 of whom had declines… PSA Drop Seen with New Prostate Cancer Drug   



kidney dysfunction1 - genital tracts1 - diabetic kidney failure1 - α-hemolysin1 - american society of clinical oncology1 - genitourinary tract2 - the journal of urology2 - urgency7 - obese patients1 - lupus2 - adequate erection1 - mortality rates1 - vascular endothelial growth factor1 - ket1 - ucsf2 - urinary system2 - buttocks1 - robotic stereotactic radiosurgery1 - klotho deficiency1 - pluripotent stem cells1 - journal of endourology1 - malaria1 - zetia1 - epidemiology1 - urine7 - disaster1 - mitotane1 - kidney stone attack1 - radical nephrectomy4 - brachytherapy2 -